Principal Financial Group Inc. Cuts Stake in Sotera Health (NASDAQ:SHC)

Principal Financial Group Inc. lowered its holdings in shares of Sotera Health (NASDAQ:SHCFree Report) by 2.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 367,955 shares of the company’s stock after selling 7,971 shares during the quarter. Principal Financial Group Inc. owned 0.13% of Sotera Health worth $5,512,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Roubaix Capital LLC lifted its holdings in shares of Sotera Health by 19.0% in the 3rd quarter. Roubaix Capital LLC now owns 408,359 shares of the company’s stock worth $6,117,000 after buying an additional 65,217 shares during the period. Ontario Teachers Pension Plan Board raised its position in shares of Sotera Health by 12.9% in the 2nd quarter. Ontario Teachers Pension Plan Board now owns 108,783 shares of the company’s stock worth $2,049,000 after acquiring an additional 12,400 shares in the last quarter. Barclays PLC raised its position in shares of Sotera Health by 699.4% in the 2nd quarter. Barclays PLC now owns 118,095 shares of the company’s stock worth $2,224,000 after acquiring an additional 103,322 shares in the last quarter. Swiss National Bank raised its position in shares of Sotera Health by 1.0% in the 2nd quarter. Swiss National Bank now owns 215,300 shares of the company’s stock worth $4,056,000 after acquiring an additional 2,100 shares in the last quarter. Finally, Strs Ohio bought a new position in shares of Sotera Health in the 3rd quarter worth $788,000. 88.89% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently commented on SHC. Royal Bank of Canada reduced their price target on Sotera Health from $22.00 to $20.00 and set an “outperform” rating for the company in a research report on Thursday, November 2nd. KeyCorp began coverage on Sotera Health in a research report on Tuesday. They set a “sector weight” rating on the stock. Finally, Barclays upped their target price on Sotera Health from $15.00 to $17.00 and gave the company an “overweight” rating in a research report on Thursday, January 25th.

Check Out Our Latest Stock Analysis on Sotera Health

Sotera Health Stock Performance

Shares of SHC stock opened at $15.62 on Wednesday. The company has a market capitalization of $4.41 billion, a P/E ratio of -14.20 and a beta of 2.20. The business’s 50 day moving average is $15.39 and its two-hundred day moving average is $15.19. The company has a current ratio of 2.59, a quick ratio of 2.40 and a debt-to-equity ratio of 6.06. Sotera Health has a 12-month low of $12.34 and a 12-month high of $19.40.

About Sotera Health

(Free Report)

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing. It also provides microbiological and analytical chemistry testing, and advisory services.

Recommended Stories

Institutional Ownership by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.